SI
DXCM icon

Sofinnova Investments’s DexCom DXCM Stock Holding History

Sofinnova Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.7M Buy
393,576
+15,357
+4% +$1.07M 0.94% 34
2025
Q4 		$25.1M Sell
378,219
-401,397
-51% -$26M 1.08% 34
2025
Q3 		$52.5M Buy
779,616
+255,922
+49% +$20.3M 2.87% 9
2025
Q2 		$45.7M Buy
523,694
+127,719
+32% +$10M 2.8% 10
2025
Q1 		$27M Buy
395,975
+105,765
+36% +$8.63M 1.77% 17
2024
Q4 		$22.6M Buy
+290,210
New +$21.5M 1.64% 20
2024
Q3 		– Sell
-61,494
Closed -$6.97M – 71
2024
Q2 		$6.97M Buy
+61,494
New +$7.77M 0.36% 50
2024
Q1 		– Sell
-20,000
Closed -$2.48M – 76
2023
Q4 		$2.48M Sell
20,000
-530,197
-96% -$54.2M 0.14% 44
2023
Q3 		$51.3M Buy
550,197
+179,477
+48% +$20.2M 3.24% 7
2023
Q2 		$47.6M Buy
370,720
+113,493
+44% +$13.7M 3.12% 11
2023
Q1 		$29.9M Buy
257,227
+116,549
+83% +$13M 1.91% 13
2022
Q4 		$15.9M Sell
140,678
-65,270
-32% -$7.17M 0.95% 26
2022
Q3 		$16.6M Buy
205,948
+16,856
+9% +$1.43M 0.97% 22
2022
Q2 		$14.1M Buy
189,092
+28,032
+17% +$2.56M 1.17% 23
2022
Q1 		$20.6M Buy
161,060
+31,444
+24% +$3.44M 1.56% 14
2021
Q4 		$17.4M Sell
129,616
-19,448
-13% -$2.79M 1.02% 26
2021
Q3 		$20.4M Buy
149,064
+14,212
+11% +$1.79M 1.21% 17
2021
Q2 		$14.4M Buy
134,852
+26,852
+25% +$2.58M 0.83% 32
2021
Q1 		$9.7M Buy
+108,000
New +$10.1M 0.58% 34

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sofinnova Investments's DXCM Position: Q1 2026 in Review

Sofinnova Investments increased its DexCom (DXCM) stake by 4.1% in Q1 2026, buying an estimated $1.07M and bringing the position to 393,576 shares worth $24.7M. The position accounts for 0.94% of the portfolio, ranked #34.

Sofinnova Investments first reported a position in DXCM in Q1 2021 and has held it in 19 quarters since. The position peaked at $52.5M in Q3 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Sofinnova Investments held 393,576 shares of DexCom worth $24.7M as of Q1 2026.
  • Sofinnova Investments bought 15,357 DexCom shares in Q1 2026, an estimated $1.07M.
  • DexCom made up 0.94% of Sofinnova Investments's portfolio in Q1 2026, its #34 holding.
  • Sofinnova Investments first reported a position in DexCom in Q1 2021 and has held it in 19 quarters since.
  • Sofinnova Investments's DexCom position peaked at $52.5M in Q3 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.